Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Medical treatment of pruritus.

Ständer S, Weisshaar E.

Expert Opin Emerg Drugs. 2012 Sep;17(3):335-45. doi: 10.1517/14728214.2012.711316. Epub 2012 Aug 7. Review.

PMID:
22870909
2.

Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.

Phan NQ, Bernhard JD, Luger TA, Ständer S.

J Am Acad Dermatol. 2010 Oct;63(4):680-8. doi: 10.1016/j.jaad.2009.08.052. Epub 2010 May 11. Review.

PMID:
20462660
3.

Chronic Pruritus: Current and Emerging Treatment Options.

Pereira MP, Ständer S.

Drugs. 2017 Jun;77(9):999-1007. doi: 10.1007/s40265-017-0746-9. Review.

PMID:
28466423
4.

Neurophysiological and neurochemical basis of modern pruritus treatment.

Ständer S, Weisshaar E, Luger TA.

Exp Dermatol. 2008 Mar;17(3):161-9. Epub 2007 Dec 5. Review.

PMID:
18070080
5.

[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].

Schulz S, Metz M, Siepmann D, Luger TA, Maurer M, Ständer S.

Hautarzt. 2009 Jul;60(7):564-8. doi: 10.1007/s00105-009-1730-4. German.

PMID:
19430742
6.

Emerging drugs for the treatment of pruritus.

Ständer S, Weisshaar E, Raap U.

Expert Opin Emerg Drugs. 2015 Sep;20(3):515-21. doi: 10.1517/14728214.2015.1051964. Epub 2015 Jun 2. Review.

PMID:
26027744
7.

Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients.

Siepmann D, Weishaupt C, Luger TA, Ständer S.

Dermatology. 2011;223(4):374-80. doi: 10.1159/000335782. Epub 2012 Feb 2.

PMID:
22301826
8.

Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.

Phan NQ, Lotts T, Antal A, Bernhard JD, Ständer S.

Acta Derm Venereol. 2012 Sep;92(5):555-60. doi: 10.2340/00015555-1353. Review.

9.

Pruritus in connective tissue and other common systemic disease states.

Galatian A, Stearns G, Grau R.

Cutis. 2009 Oct;84(4):207-14. Review.

PMID:
19911676
10.

Chronic pruritus.

Ständer S, Grundmann SA.

G Ital Dermatol Venereol. 2012 Apr;147(2):161-9. Review.

PMID:
22481579
11.

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.

Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA.

PLoS One. 2010 Jun 4;5(6):e10968. doi: 10.1371/journal.pone.0010968.

12.

Chronic pruritus: targets, mechanisms and future therapies.

Pogatzki-Zahn E, Marziniak M, Schneider G, Luger TA, Ständer S.

Drug News Perspect. 2008 Dec;21(10):541-51. doi: 10.1358/dnp.2008.21.10.1314057. Review.

PMID:
19221635
13.

Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials.

Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ, Szepietowski JC; International Forum for the Study of Itch Special Interest Group Scoring Itch in Clinical Trials.

Acta Derm Venereol. 2013 Sep 4;93(5):509-14. doi: 10.2340/00015555-1620.

14.

Investigational drugs for pruritus.

Benecke H, Lotts T, Ständer S.

Expert Opin Investig Drugs. 2013 Sep;22(9):1167-79. doi: 10.1517/13543784.2013.813932. Epub 2013 Jul 2. Review.

PMID:
23815605
15.

[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].

Zenker S, Schuh T, Degitz K.

J Dtsch Dermatol Ges. 2003 Sep;1(9):705-10. German.

PMID:
16285277
16.

[Chronic pruritus: principals of diagnostics and therapy].

Ständer S.

Hautarzt. 2007 Jul;58(7):627-36; quiz 637. Review. German.

PMID:
17572867
17.

Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.

Cevikbas F, Steinhoff M, Ikoma A.

CNS Neurosci Ther. 2011 Dec;17(6):742-9. doi: 10.1111/j.1755-5949.2010.00201.x. Epub 2010 Oct 15. Review.

PMID:
20950328
18.

Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.

Weisshaar E, Dunker N, Röhl FW, Gollnick H.

Exp Dermatol. 2004 May;13(5):298-304.

PMID:
15140020
19.

A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.

Tamdee D, Charuluxananan S, Punjasawadwong Y, Tawichasri C, Patumanond J, Sriprajittichai P.

Anesth Analg. 2009 Nov;109(5):1606-11. doi: 10.1213/ANE.0b013e3181b72e93.

PMID:
19843798
20.

Pruritus: an overview of current concepts.

Metz M, Grundmann S, Ständer S.

Vet Dermatol. 2011 Apr;22(2):121-31. doi: 10.1111/j.1365-3164.2010.00945.x. Epub 2011 Jan 20. Review.

PMID:
21251097

Supplemental Content

Support Center